Updates

August 15, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Corporate Relationship Department Plot No. C-1, G- Block, 25, P.J. Towers, Bandra - Kurla Complex, Bandra (East) Dalal Street, Mumbai – 400 051. Mumbai 400 001. Symbol: RPGLIFE Scrip Code: 532983 Dear Sir/Madam, Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Further investment in RPG Active Pharma Limited ('RPGAP'). Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions, we wish to inform you that the Company has made an investment up to Rs.65,68,60,500 (Rupees Sixty-Five Crores Sixty-Eight Lakhs Sixty Thousand and Five Hundred Only) by way of subscription in Rights Issue of equity shares of RPG Active Pharma Limited (‘RPGAP’), a wholly owned subsidiary of the Company. Information pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, read with relevant SEBI Circular(s) are enclosed herewith. The above information will also be available on the website of the Company www.rpglifesciences.com. Kindly take the same on record. Thanking you, Yours faithfully, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary Encl.: as above Annexure - A Disclosure Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Name of the target entity, details in brief RPG Active Pharma Limited (‘RPGAP’) is a wholly such as size, turnover etc. owned subsidiary company, has an authorized share capital of Rs. 7,00,00,000 (Rupees Seven Crores only) and paid-up capital of Rs. 1,16,85,000 (Rupees One Crore Sixteen Lakhs and Eight-Five Thousand only). RPGAP is yet to commence operations and does not have any turnover. Whether the acquisition would fall within The current investment falls under the purview of the related party transaction(s) and whether transaction with related parties under Section 177 of the promoter/ promoter group/ group the Companies Act, 2013 and Regulation 23 of SEBI companies have any interest in the entity (Listing Obligations and Disclosure Requirements) being acquired? If yes, nature of interest Regulations, 2015 and the transaction is at arm's and details thereof and whether the same length. is done at "arm's length" Except to the extent of being a wholly owned subsidiary of RPG Life Sciences Limited (‘RPGLS’), the Promoter / promoter group/ group companies of (‘RPGLS’) do not have any interest in RPGAP in the transaction. Industry to which the entity being Pharmaceutical Industry. acquired belongs Objects and impact of acquisition Proposed investment is in the equity shares of a (including but not limited to, disclosure wholly owned subsidiary. of reasons for acquisition of target entity, if its business is outside the main line of The Company’s shareholding post this proposed business of the listed entity) investment remains 100%. Brief details of any governmental or NA regulatory approvals required for the acquisition Indicative time period for completion of 21,89,535 equity shares pursuant to the current the acquisition investment allotted on August 14, 2026, to the Company by RPGAP. Consideration - whether cash Cash Consideration by way of remittance through consideration or share swap or any normal banking channel. other form and details of the same Cost of acquisition and / or the price at Up to Rs. 65,68,60,500 (Rupees Sixty-Five Crores which the shares are acquired Sixty-Eight Lakhs Sixty Thousand and Five Hundred only) towards the proposed subscription of 21,89,535 equity shares of face value Re.10/- each fully paid up. Percentage of shareholding / control With the proposed current investment, the acquired and / or number of shares Company’s shareholding in RPGAP remains 100%. acquired Brief background about the entity RPGAP is a public company incorporated on acquired in terms of products/line of December 24, 2025, with its registered office in business acquired, date of incorporation, Mumbai, India. history of last 3 years’ turnover, country RPGAP is yet to commence operations and does not in which the acquired entity has presence have any turnover. and any other significant information (in brief)